Cleared Special

K223127 - HemoSphere Advanced Monitoring Platform

K223127 is an FDA 510(k) clearance for HemoSphere Advanced Monitoring Platform, manufactured by Edwards Lifeciences, LLC. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 35-day FDA review.

K223127 · Edwards Lifeciences, LLC · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
35d
Days
Class 2
Risk

K223127 is an FDA 510(k) clearance for the HemoSphere Advanced Monitoring Platform, HemoSphere ForeSight Oximeter cable. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Edwards Lifeciences, LLC (Irvine, US). The FDA issued a Cleared decision on November 7, 2022 after a review of 35 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Edwards Lifeciences, LLC devices

FDA 510(k) Submission Details - K223127

510(k) Number K223127 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 03, 2022
Decision Date November 07, 2022
Days to Decision 35 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 125d · This submission: 35d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 270
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K223127.
EnSite™ X EP System TactiFlex™ Ablation Catheter, Sensor Enabled™, Software Upgrade
K223094 · Abbott Medical · Dec 2022
STAR Apollo Mapping System
K220786 · Rhythm Al, Ltd. · Dec 2022
HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI)
K221704 · Edwards Lifesciences, LLC · Nov 2022
KODEX – EPD™ System 1.5.0
K212493 · Philips Medical Systems Nederland, B.V. (Pmsn) · Oct 2022
AcQMap High Resolution Imaging and Mapping System
K222209 · Acutus Medical, Inc. · Oct 2022
EnSite X EP System
K221213 · Abbott · Aug 2022